EGFR and neoplasm: To assess the clinical significance of our studies, we investigated the effects of dasatinib treatment and the potential of [89Zr]Zr-cetuximab to monitor changes in EGFR membrane abundance in an EGFR-expressing TNBC PDX tumor model.